DK0637451T3 - Virussikkert blodkoagulationsfaktor XIII-præparat - Google Patents

Virussikkert blodkoagulationsfaktor XIII-præparat

Info

Publication number
DK0637451T3
DK0637451T3 DK94890132T DK94890132T DK0637451T3 DK 0637451 T3 DK0637451 T3 DK 0637451T3 DK 94890132 T DK94890132 T DK 94890132T DK 94890132 T DK94890132 T DK 94890132T DK 0637451 T3 DK0637451 T3 DK 0637451T3
Authority
DK
Denmark
Prior art keywords
blood coagulation
coagulation factor
factor xiii
virus
safe blood
Prior art date
Application number
DK94890132T
Other languages
English (en)
Inventor
Thomas Dr Seelich
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK0637451T3 publication Critical patent/DK0637451T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK94890132T 1993-08-03 1994-08-03 Virussikkert blodkoagulationsfaktor XIII-præparat DK0637451T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0154893A AT402788B (de) 1993-08-03 1993-08-03 Virussichere blutgerinnungsfaktor xiii-präparation

Publications (1)

Publication Number Publication Date
DK0637451T3 true DK0637451T3 (da) 2000-04-03

Family

ID=3515781

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94890132T DK0637451T3 (da) 1993-08-03 1994-08-03 Virussikkert blodkoagulationsfaktor XIII-præparat

Country Status (8)

Country Link
US (1) US5610147A (da)
EP (1) EP0637451B1 (da)
JP (1) JP3692153B2 (da)
AT (2) AT402788B (da)
CA (1) CA2128795C (da)
DE (1) DE59408814D1 (da)
DK (1) DK0637451T3 (da)
ES (1) ES2141214T3 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
AT402788B (de) * 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
DE19521324C1 (de) * 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
AT405135B (de) * 1997-01-17 1999-05-25 Immuno Ag Präparation umfassend thiolgruppen-hältige proteine
AT404358B (de) 1997-02-04 1998-11-25 Immuno Ag Verfahren zur chromatographischen reinigung bzw. fraktionierung von von willebrand-faktor aus einem vwf-hältigen ausgangsmaterial
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
US6168788B1 (en) 1997-09-26 2001-01-02 Leon Wortham Fibrin glue without fibrinogen and biosealant compositions and methods
SI1151007T1 (sl) 1999-02-12 2006-10-31 Baxter Ag Postopek za pripravo pripravka na osnovi fibrinogena in fibronektina in proteinski sestavki, ki jihlahko dobimo po tem postopku
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren
AT410218B (de) 1999-08-20 2003-03-25 Baxter Ag Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben
WO2002005898A1 (en) * 2000-07-17 2002-01-24 Haemacure Corporation Spray head for applying a multi-component mixture
EP1425034A4 (en) * 2001-09-10 2005-09-21 Zymogenetics Inc METHOD FOR THE TREATMENT OF CUMARIN-INDUCED BLEEDING
DE102004037805B3 (de) * 2004-08-03 2006-03-23 Zlb Behring Gmbh Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen
ES2640343T3 (es) * 2008-04-21 2017-11-02 Novo Nordisk Health Care Ag Composición de transglutaminasa anhidra
US8741845B1 (en) * 2009-06-18 2014-06-03 Biomedica Mangement Corporation Lyophilized fibrin sealant for high volume hemorrhage

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
AT376883B (de) * 1983-05-02 1985-01-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
AT390001B (de) * 1984-09-28 1990-03-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
JPS6380960A (ja) * 1986-09-26 1988-04-11 Fuji Seiki Seizosho:Kk ハンダ付方法
ES2057191T5 (es) * 1989-01-13 2003-05-01 Mitsubishi Pharma Corp Metodo de produccion para una composicion que contiene proteinas.
JPH03106824A (ja) * 1989-09-18 1991-05-07 Green Cross Corp:The 血液凝固第ｘ３因子の加熱処理方法
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AT402788B (de) * 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation

Also Published As

Publication number Publication date
DE59408814D1 (de) 1999-11-18
ATA154893A (de) 1997-01-15
US5610147A (en) 1997-03-11
EP0637451B1 (de) 1999-10-13
EP0637451A1 (de) 1995-02-08
CA2128795C (en) 1999-09-07
ATE185488T1 (de) 1999-10-15
JPH0753402A (ja) 1995-02-28
ES2141214T3 (es) 2000-03-16
CA2128795A1 (en) 1995-02-04
JP3692153B2 (ja) 2005-09-07
AT402788B (de) 1997-08-25

Similar Documents

Publication Publication Date Title
DE59408814D1 (de) Virussichere Blutgerinnungsfaktor XIII-Präparation
NO930294D0 (no) Stabil fibrinogenopploesning
PT725824E (pt) Epitopos de celulas t humanas imunodominantes do virus da hepatite c
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
AU3698697A (en) Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicament
HUT65390A (en) Thrombin and method for its preparation
EP0519901A3 (en) Virus-inactivated blood product
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
DE60237791D1 (de) Zytokinproteinfamilie
ATE262315T1 (de) Stabilisiertes wässriges flüssiges blutgerinnungsfaktor xiii-präparat
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
ATE130630T1 (de) Sg(beta)-1,4-galaktanase und dns-sequenz.
DE59309752D1 (de) Sterilisiergasgemisch
DE59710091D1 (de) Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
DE453719T1 (de) Bakteriozin-peptid.
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
JPS6419023A (en) Heat treatment of fibrinogen and fibrinogen preparation
DE3863499D1 (de) Schaedlingsbekaempfungsmittel auf basis von derivaten des 2,3-diaminomaleinsaeurenitrils.
WO2003038095A3 (fr) Peptide isole du facteur de croissance hepatocytaire et ses variants, procede de preparation et utilisation en therapeutique en tant qu'agents antiangiogeniques
HUP9601528A2 (hu) Véralvadásgátló hatású peptidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények
EP0953642A4 (en) ANTIGENIC PROTEIN DRAWN FROM THE INFECTIOUS LARYNGO-TRACHEITIS VIRUS